Skip to content

Teleport Microcatheter 220-15-1000URecalls & reported problems

OrbusNeich Medical (ShenZhen) Co., Ltd. · Caatheter, Percutaneous · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 06934955943065), received between Mar 24, 2019 and Mar 24, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Failure to Advance” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Failure to Advance1
  • Fracture1
  • Stretched1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 24, 2019Fracture; Stretched; Failure to Advance

    THE MICROCATHETER COULD NOT CROSS THE LESION AND BECAME STUCK AT THE SAME LOCATION AS THE PREVIOUS DEVICE. ADDITIONAL FORCE WAS APPLIED TO REMOVE THE MICROCATHETER AND THE MICROCATHETER FRACTURED AND STRETCHED DURING REMOVAL. THE PROCEDURE WAS COMPLETED WITH ANGIOPLASTY AND ATHERECTOMY. THE VESSEL WAS 95% STENOTIC WITH A DIAMETER OF 3.5MM AND SEVERE CALCIFICATION.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8446663 ↗

Other Catheter, Percutaneous devices

All Catheter, Percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page